{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001130123.2:c.253G>A",
          "cDNA Change": {
            "transcript": "NM_001130123.2",
            "ref": "G",
            "alt": "A",
            "position": "253"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "85"
          },
          "Description in input context": "c.253G>A (p.G85D) in alpha-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005333"
  },
  "Experiment Method": [
    {
      "Assay Method": "Amyloid fibril formation assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells overexpressing SNCA variants",
        "Description": "HEK293 cells were transfected with plasmids encoding wild-type or mutant SNCA."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130123.2:c.253G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The p.G85D variant accelerated amyloid fibril formation compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent transfections were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each transfection was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA plasmid was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-way ANOVA with post-hoc Tukey's test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Amyloid fibril formation rate < 20% at 24 hours.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Amyloid fibril formation rate â‰¥ 40% at 24 hours.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}